In this respect, the potential relevance of survivin for monitoring response to preoperative chemoradiotherapy has recently been confirmed by Sprenger and colleagues who could show that high survivin expression in pretreatment biopsies correlated with advanced posttherapeutical tumor and UICC stage and decreased disease-free survival [95]. This evidence concerns the gene BIRC5 and neoplasm.